Daly Jason B.

CIK 00019064861 companyBRIDGEWATER, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001906486

Recent Transactions

50 trades

Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2026-03-04−35,880→ 71,760 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-04+35,880→ 267,364 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-04$13.30/sh−15,580→ 251,784 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2026-03-03−24,258→ 72,774 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2026-03-03−22,645→ 0 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03$13.31/sh−132,783→ 231,484 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03$13.31/sh−10,533→ 58,457 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03+24,258→ 68,990 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03$13.31/sh−16,598→ 44,732 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03+38,226→ 61,330 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03$13.31/sh−10,147→ 23,104 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03+22,645→ 33,251 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2026-03-03−305,810→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2026-03-03−38,226→ 38,227 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03+305,810→ 364,267 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2026-03-02+65,359→ 65,359 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2026-03-02+65,359→ 65,359 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-08-12$9.05/sh−22,000→ 10,606 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-06$8.73/sh−46,936→ 32,606 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-05$8.88/sh−43,064→ 79,542 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-04−35,879→ 107,640 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-04+35,879→ 138,185 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-04$8.84/sh−15,579→ 122,606 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2025-03-03+194,064→ 194,064 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+22,645→ 22,645 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−6,943→ 15,702 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+38,226→ 53,928 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−10,864→ 43,064 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+90,580→ 133,644 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−31,338→ 102,306 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03−22,645→ 22,645 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2025-03-03−90,580→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03−38,226→ 76,453 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03+97,032→ 97,032 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-11-21$8.40/sh−13,665→ 0 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-11-15$8.61/sh−43,657→ 13,665 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2024-03-04+287,038→ 287,038 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-04+143,519→ 143,519 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03$5.47/sh−7,166→ 29,960 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-03−38,226→ 114,679 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-03−22,645→ 45,290 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03$5.47/sh−10,864→ 57,322 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03+38,226→ 68,186 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03+22,645→ 37,126 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-03-03−22,645→ 67,935 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-03-03$1.92/sh−8,164→ 14,481 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-03-03+22,645→ 22,645 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-03-03+152,905→ 152,905 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2023-03-03+305,810→ 305,810 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2022-03-03+181,160→ 181,160 total

Companies

Amneal Pharmaceuticals, Inc.
EVP, Chief Legal Officer
$AMRX

Recent Filings

Address

C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD

BRIDGEWATER, NJ, 08807

View on SEC.gov